SCHEMBL2654876

SCHEMBL2654876

Cc1ccc(OCC(C)CCc2ccc(C(=O)NCCC(=O)O)cc2)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GCG P01275 4/20 0.45
GCGR P47871 10/20 0.41
GIPR P48546 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 1/20 0.41
FABP2 P12104 1/20 0.41
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
VIPR2 P41587 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656922 0.88 GCGR (0.49) GCGGCGRGIPRSMN1; SMN2ALDH1A1
SCHEMBL2654806 0.86 GCGR (0.49) GCGGCGRGIPRSMN1; SMN2NPC1
SCHEMBL2653970 0.85 GCGR (0.49) GCGGCGRGIPRSMN1; SMN2ALDH1A1
SCHEMBL2655144 0.84 GCGR (0.49) GCGGCGRSMN1; SMN2MAPTNPC1
SCHEMBL2655131 0.84 GCG (0.44) GCGGCGRGIPRSMN1; SMN2ALDH1A1
SCHEMBL2654589 0.83 GCGR (0.48) GCGRGIPRPPARD
SCHEMBL2653405 0.83 GCGR (0.53) GCGGCGRGIPRSMN1; SMN2ALDH1A1
SCHEMBL2654012 0.83 GCGR (0.49) GCGRGIPRNPC1RAB9A
SCHEMBL2653538 0.82 GCGR (0.51) GCGGCGRGIPRVIPR2
SCHEMBL2657098 0.82 GCGR (0.49) GCGGCGRGIPRHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP claimed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO claimed
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed